Advertisement Thorne Research gets Qcell marketing rights from Helsinn - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Thorne Research gets Qcell marketing rights from Helsinn

Thorne Research, a provider of dietary supplements, has got all marketing rights of Qcell from Helsinn Pharmaceuticals.

Qcell is an advanced formulation of Coenzyme Q10 (CoQ10) supplement formerly marketed under the brand name Q-Best.

Qcell has demonstrated increased absorption rates by up to 10-fold compared to dry-powder formulation CoQ10 supplements.

University of Michigan Department of Family Medicine Andrew Heyman said the important role that CoQ10 plays in human health has been long established, and factors including disease, aging, and treatment with certain drug therapies can all reduce levels of naturally-occurring CoQ10 in humans.

"QCell is based on an advanced formulation that significantly improves absorption and bioavailability to improve patient outcomes," Heyman said.